瑞博生物
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Ribo Granted EMA Orphan Drug Designation for siRNA Therapeutic RBD1016 for Hepatitis Delta Virus (HDV) Infection 2025-10-24 18:12
Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases 2024-01-03 19:37
1